GSK announces positive results from Blenrep phase 3 blood cancer trial
(Alliance News) - GSK PLC on Monday said a phase 3 trial of belantamab mafodotin as a multiple myeloma treatment has produced positive headline results. Read More
Price | 1,411.80p on 28-11-2023 | at 18:45:08
---|---|
Change | -2.40p -0.17% |
Buy | 1,410.40p |
Sell | 1,410.00p |
Buy / Sell GSK Shares |
Last Trade: | Unknown 1,377.00 at 1,412.08p |
Day's Volume: | 5,168,369 |
Last Close: | 1,411.80p |
Open: | 1,408.20p |
ISIN: | GB00BN7SWP63 |
Day's Range | 1,395.00p - 1,411.80p |
52wk Range: | 1,302.60p - 1,609.00p |
Market Capitalisation: | £57,814m |
VWAP: | 1,409.10162p |
Shares in Issue: | 4,095m |
Recent Trades History Glaxosmithkline (GSK) |
||||
Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
---|---|---|---|---|
Unknown* | 1,377 | 1,412.08p | Ordinary Currency Conversion OTC Trade |
18:45:06 - 28-Nov-23 |
Unknown* | 1,056 | 1,400.79734p | Ordinary Currency Conversion OTC Trade |
17:57:42 - 28-Nov-23 |
Unknown* | 1,154 | 1,408.79p | Ordinary Currency Conversion OTC Trade |
17:54:18 - 28-Nov-23 |
Unknown* | 1,542 | 1,404.671p | Ordinary Currency Conversion OTC Trade |
17:54:18 - 28-Nov-23 |
Unknown* | 1,211 | 1,406.491p | Ordinary Currency Conversion OTC Trade |
17:54:18 - 28-Nov-23 |
Unknown* | 1,649 | 1,404.177p | Ordinary Currency Conversion OTC Trade |
17:54:18 - 28-Nov-23 |
Unknown* | 1,325 | 1,407.003p | Ordinary Currency Conversion OTC Trade |
17:54:18 - 28-Nov-23 |
Unknown* | 8,483 | 1,405.405p | Ordinary Currency Conversion OTC Trade |
17:54:18 - 28-Nov-23 |
Unknown* | 159,784 | 1,407.415p | Ordinary Currency Conversion OTC Trade |
17:54:18 - 28-Nov-23 |
Unknown* | 1,929 | 1,408.206p | Ordinary Currency Conversion OTC Trade |
17:54:18 - 28-Nov-23 |